Please login to the form below

Not currently logged in
Email:
Password:

Surface Oncology

This page shows the latest Surface Oncology news and features for those working in and with pharma, biotech and healthcare.

GSK signs collaboration deal with Ligand targeting neurological disorders

GSK signs collaboration deal with Ligand targeting neurological disorders

This includes a deal announced last week with Surface Oncology for access to the biotech’s lead preclinical oncology asset. ... GSK paid $85m upfront for Surface’s asset SRF813, a fully human IgG1 antibody targeting PVRIG – an inhibitory protein

Latest news

  • GSK pays $85m upfront for Surface Oncology’s lead cancer drug GSK pays $85m upfront for Surface Oncology’s lead cancer drug

    British pharma company adds preclinical antibody to its pipeline. GlaxoSmithKline (GSK) has added a preclinical oncology asset to its pipeline after paying $85m upfront for Surface Oncology’s lead asset. ... Novartis signed an agreement with Surface

  • Sanofi and Novartis snap up immuno-oncology candidates Sanofi and Novartis snap up immuno-oncology candidates

    Details of the Novartis agreement are sketchy, but the company says it has licensed four preclinical programmes from Massachusetts-based Surface Oncology's portfolio which target "regulatory T cell populations, inhibitory ... The candidates will be

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics